Skip to content

Pediatric Robotic Versus Open Pyeloplasty

Pediatric Robotic Versus Open Pyeloplasty: A Pilot Randomized Control Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04884945
Enrollment
11
Registered
2021-05-13
Start date
2017-10-24
Completion date
2021-06-23
Last updated
2024-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Urology, Ureteropelvic Junction Obstruction

Keywords

patient centered outcomes

Brief summary

The objective is conduct a pilot randomized controlled trial comparing robotic and open techniques for surgical correction of congenital UPJ obstruction (pyeloplasty) in pediatric patients. This study will serve as a proof of concept trial to demonstrate feasibility of recruiting pediatric patients to participate in a randomized study for surgical procedures and delineate patient-centered outcomes. Should this study prove randomization is feasible, a randomized comparative effectiveness trial with sufficient power to determine whether open or robotic-assisted pyeloplasty has superior patient-centered outcomes will be pursued.

Detailed description

Technological innovations are an ongoing reality in clinical medicine, most dramatically in the operating room. Each advance is often heralded as an improvement in patient care, promising to correct deficiencies and advance standard operative procedures. Unfortunately, these new technologies often lack sufficient evidence to support such claims. Robotic assisted laparoscopic (RAL) surgery continues to gain popularity among pediatric surgical specialists, particularly for reconstructive procedures such as correction of ureteropelvic junction (UPJ) obstruction or vesicoureteral reflux (VUR).In these operations, where traditional open surgery yields a nearly 95% clinical success rate it is difficult to demonstrate improvement with a new surgical technique. Despite these impressive outcomes with the open approach many pediatric urologists are shifting towards newer RAL approaches, claiming faster recovery and improved cosmesis with a nominal increase in surgical cost. There is a striking dearth of comparative effectiveness research in pediatric surgical specialties, especially given the wide range of available therapies for a variety of surgical problems. Conducting randomized controlled trials of surgical interventions can be very difficult, especially in the pediatric population. Currently, all studies of pediatric robotic surgery have focused on traditional outcomes, e.g., length of stay, pain scores, pain medication usage, scar perception, cost analysis, and capital gains benefits. While these measures are important to study, the investigators believe that researchers must also focus on patients' treatment experiences or patients' evaluations of their own outcomes. By focusing on these 'patient-centered outcomes' the investigators will be able to improve outcomes from surgical procedures in ways that are most important to patients and their families. We propose a pilot randomized controlled trial comparing robotic and open techniques for surgical correction of congenital UPJ obstruction (pyeloplasty) in pediatric patients. This study will serve as a proof of concept trial to demonstrate feasibility of recruiting pediatric patients to participate in a randomized study for surgical procedures and delineate patient-centered outcomes. Should this study prove randomization is feasible, the investigators will seek funding to conduct a large, randomized comparative effectiveness trial with sufficient power to determine whether open or robotic-assisted pyeloplasty has superior patient-centered outcomes. The investigators propose to accomplish these goals with the following Specific Aims: Aim 1: Utilize novel patient-centered research methods to: * Identify outcomes of importance to patients and families related to pediatric pyeloplasty. * Determine patient and family preferences regarding acceptability of randomization and blinding of pediatric surgical patients and construct a recruitment approach to achieve enrollment. Aim 2: Conduct a randomized pilot study with goal of enrolling ten to twenty pediatric patients (age 2 - 8 years) to either open or robotic pyeloplasty for treatment of primary UPJ obstruction. Sub Aim 2a: Collect preliminary data regarding the patient-centered outcomes identified in Aim 1. Sub Aim 2b: Evaluate the effectiveness of the recruitment approach for randomized surgical studies developed in Aim 1. The investigators believe that the use of innovative and novel patient-centered research methods will lead to a significant breakthrough in developing a recruitment approach that is both acceptable to pediatric patients/families and optimizes participant willingness to participate in RCTs of surgical interventions. Additionally these same innovative research methods will allows the investigators to explore what outcomes are meaningful to patients and families, which will hopefully allow the care team to counsel patients and families in a way that maximizes their chances of achieving patient- and family-centered goals.

Interventions

PROCEDUREOpen Pyeloplasty (OP)

Open approach for the surgical correction of UPJ obstruction

DEVICERobotic-Assisted Laparoscopic Pyeloplasty (RALP)

Robotic approach with the da Vinci Surgical System for the surgical correction of UPJ obstruction

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Caregiver)

Masking description

Patient, Family, and Nursing Staff on Surgical Floor

Intervention model description

For Aim 2: For the RCT, patients are randomized to either RALP or OP by using a pool of 20 cards of which 10 say robotic surgery and 10 say open surgery.

Eligibility

Sex/Gender
ALL
Age
2 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

For Aim 2: Inclusion Criteria: * Primary UPJ obstruction diagnosed by scan and presenting to the pediatric urology clinic for evaluation * Patient between age 2 - 8 years old

Exclusion criteria

* Serious comorbidities (cardiovascular or respiratory disease, or other congenital anomalies requiring surgical intervention). * BMI greater than the 95th %tile for age.

Design outcomes

Primary

MeasureTime frameDescription
Pain Score Measured Using The FLACC at 2 Week Post Op Follow Up1 week post op follow upObtained from hospital record and participant report post discharge via the FLACC (behavioral scale for scoring postoperative pain in young children). FLACC score range: minimum 0 ( comfortable) and 10 (severe discomfort)
Length of Post Op Inpatient Hospital Stay Measured in Dayssurgery to dischargeNumber of inpatient hospital days post surgery obtained via retrospective chart.
Number of Doses of Narcotic Pain Medication In the First 24 Hours Post OpSurgery to the first 24 hours post opPain medication use during hospitalization obtained via retrospective chart review. Dose recorded in mg and frequency recorded as number of doses administered in 24 hour period
Total Dose of Narcotic Pain Medication In the First 24 Hours Post Op in Morphine Milligram Equivalents (MME)Surgery to the first 24 hours post opPain medication use during hospitalization obtained via retrospective chart review. Morphine milligram equivalents (MME) are values that represent the potency of an opioid dose relative to morphine
Grade of Surgical Complications up to 1 Year Post op Using Clavian-Dindo Classificationup to 1 year post upThis s a standardized scale to rank the severity of a surgical complication. The higher the grade the more severe the surgical complication. Minimum value is Grade 0 no complication to maximum Grade IV life threatening complication. Grades I thru IV defined as: Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. This grade also includes wound infections opened at the bedside ; Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusionsand total parenteral nutritionare also included; Grade III Requiring surgical, endoscopic or radiological intervention; Grade IV Life-threatening complication (including CNS complications)\* requiring IC/ICU-management
Length Of Time For Patient To Return To Normal Routine After Surgery Measured in Days at 2 Week Post Follow Up2 week post op follow upStudy team created a questionnaire to better understand patient's post op experience. Participant to complete questionnaire with targeted questions on: Side effects of medication and impact; Experience of having a temporary ureteral stent; Ease of removing stent; Return to activity; Financial burden reported by family. No scale or scoring utilized to assess outcome.
Length Of Time Parent Was Out Of Work After Child's Surgery Measured in Days at 2 Week Post Follow Up2 week post op follow upNumber of days parent out of work after operation obtained by parent report. No scale or scoring utilized to assess outcome. Participant asked Have you returned to work since your child's surgery?. If Yes, asked to estimate the length of time you were out of work after your child's operation.
Satisfaction With Scar Appearance Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visitup to 3 month follow up visit (18 weeks post op)Participant completed the Patient Scar Assessment Questionnaire (PSAQ) at 3 month follow up visit. The 3 month follow up was scheduled at the 6 week post op visit. The Satisfaction with Appearance subscale consists of a 8 items with 4-point categorical responses, scoring 1 to 4 points (with 1 point assigned to the most favourable category and 4 assigned to the least favourable). The minimum score of this scale is an 8 and maximum 32.
Satisfaction With Symptoms Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visitup to 3 month follow up visit (18 weeks post op)The Patient Scar Assessment Questionnaire (PSAQ) was completed at the 3 month follow up (scheduled at the 6 week post op visit). Higher scores reflect a poorer perception of the scar related to the domain being evaluated. The Satisfaction with Symptoms subscale consists of a 5 items with 4-point categorical responses, scoring 1 to 4 points (with 1 point assigned to the most favourable category and 4 assigned to the least favourable). The minimum score of this scale is an 5 and maximum 20.
Quality of Life Measured Using The Glasgow Children's Benefit Inventory at 3 Month Follow Up Visit3 month follow up visitParticipant completed the GCBI at 3 month follow up visit. The 3 month follow up was scheduled at the 6 week post op visit. The Glasgow Children's Benefit Inventory (GCBI). is a 24 question 5 point Likert scale 2 (much better) to -2 (much worse) with scoring range from -100 (maximum harm) to +100 (maximum benefit).

Countries

United States

Participant flow

Participants by arm

ArmCount
Robotic Surgery
Robotic-Assisted Laparoscopic Pyeloplasty (RALP), standard of care treatment option for UPJ obstruction Robotic-Assisted Laparoscopic Pyeloplasty (RALP): Robotic approach with the da Vinci Surgical System for the surgical correction of UPJ obstruction
5
Open Surgery
Open Pyeloplasty (OP), standard of care treatment option for UPJ obstruction Open Pyeloplasty (OP): Open approach for the surgical correction of UPJ obstruction
6
Total11

Baseline characteristics

CharacteristicRobotic SurgeryOpen SurgeryTotal
Age, Customized
Age 2 to 8 years
5 Participants6 Participants11 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
5 Participants3 Participants8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants3 Participants3 Participants
Region of Enrollment
United States
5 participants6 participants11 participants
Sex: Female, Male
Female
3 Participants0 Participants3 Participants
Sex: Female, Male
Male
2 Participants6 Participants8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 6
other
Total, other adverse events
0 / 50 / 6
serious
Total, serious adverse events
0 / 50 / 6

Outcome results

Primary

Grade of Surgical Complications up to 1 Year Post op Using Clavian-Dindo Classification

This s a standardized scale to rank the severity of a surgical complication. The higher the grade the more severe the surgical complication. Minimum value is Grade 0 no complication to maximum Grade IV life threatening complication. Grades I thru IV defined as: Grade I Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. This grade also includes wound infections opened at the bedside ; Grade II Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusionsand total parenteral nutritionare also included; Grade III Requiring surgical, endoscopic or radiological intervention; Grade IV Life-threatening complication (including CNS complications)\* requiring IC/ICU-management

Time frame: up to 1 year post up

ArmMeasureValue (MEAN)Dispersion
Robotic SurgeryGrade of Surgical Complications up to 1 Year Post op Using Clavian-Dindo Classification0.6 grade on a scaleStandard Deviation 1.34
Open SurgeryGrade of Surgical Complications up to 1 Year Post op Using Clavian-Dindo Classification0 grade on a scaleStandard Deviation 0
Primary

Length of Post Op Inpatient Hospital Stay Measured in Days

Number of inpatient hospital days post surgery obtained via retrospective chart.

Time frame: surgery to discharge

ArmMeasureValue (MEAN)Dispersion
Robotic SurgeryLength of Post Op Inpatient Hospital Stay Measured in Days1 daysStandard Deviation 0
Open SurgeryLength of Post Op Inpatient Hospital Stay Measured in Days1 daysStandard Deviation 0
Primary

Length Of Time For Patient To Return To Normal Routine After Surgery Measured in Days at 2 Week Post Follow Up

Study team created a questionnaire to better understand patient's post op experience. Participant to complete questionnaire with targeted questions on: Side effects of medication and impact; Experience of having a temporary ureteral stent; Ease of removing stent; Return to activity; Financial burden reported by family. No scale or scoring utilized to assess outcome.

Time frame: 2 week post op follow up

Population: Participant asked At this point in your child's post op recovery, has your home routine returned to normal? If participant responded Yes then participant asked Estimate the length of time length of time it took to return to normal.

ArmMeasureValue (MEAN)Dispersion
Robotic SurgeryLength Of Time For Patient To Return To Normal Routine After Surgery Measured in Days at 2 Week Post Follow Up7.67 daysStandard Deviation 5.03
Open SurgeryLength Of Time For Patient To Return To Normal Routine After Surgery Measured in Days at 2 Week Post Follow Up6.5 daysStandard Deviation 3.73
Primary

Length Of Time Parent Was Out Of Work After Child's Surgery Measured in Days at 2 Week Post Follow Up

Number of days parent out of work after operation obtained by parent report. No scale or scoring utilized to assess outcome. Participant asked Have you returned to work since your child's surgery?. If Yes, asked to estimate the length of time you were out of work after your child's operation.

Time frame: 2 week post op follow up

ArmMeasureValue (MEAN)Dispersion
Robotic SurgeryLength Of Time Parent Was Out Of Work After Child's Surgery Measured in Days at 2 Week Post Follow Up3.33 daysStandard Deviation 3.51
Open SurgeryLength Of Time Parent Was Out Of Work After Child's Surgery Measured in Days at 2 Week Post Follow Up5 daysStandard Deviation 3.92
Primary

Number of Doses of Narcotic Pain Medication In the First 24 Hours Post Op

Pain medication use during hospitalization obtained via retrospective chart review. Dose recorded in mg and frequency recorded as number of doses administered in 24 hour period

Time frame: Surgery to the first 24 hours post op

ArmMeasureValue (MEAN)Dispersion
Robotic SurgeryNumber of Doses of Narcotic Pain Medication In the First 24 Hours Post Op0.600 Number of DosesStandard Deviation 0.55
Open SurgeryNumber of Doses of Narcotic Pain Medication In the First 24 Hours Post Op0.500 Number of DosesStandard Deviation 0.55
Primary

Pain Score Measured Using The FLACC at 2 Week Post Op Follow Up

Obtained from hospital record and participant report post discharge via the FLACC (behavioral scale for scoring postoperative pain in young children). FLACC score range: minimum 0 ( comfortable) and 10 (severe discomfort)

Time frame: 1 week post op follow up

Population: FLACC scores 2 week post op

ArmMeasureValue (MEAN)Dispersion
Robotic SurgeryPain Score Measured Using The FLACC at 2 Week Post Op Follow Up2.5 score on a scaleStandard Deviation 3.7
Open SurgeryPain Score Measured Using The FLACC at 2 Week Post Op Follow Up0 score on a scaleStandard Deviation 0
Primary

Quality of Life Measured Using The Glasgow Children's Benefit Inventory at 3 Month Follow Up Visit

Participant completed the GCBI at 3 month follow up visit. The 3 month follow up was scheduled at the 6 week post op visit. The Glasgow Children's Benefit Inventory (GCBI). is a 24 question 5 point Likert scale 2 (much better) to -2 (much worse) with scoring range from -100 (maximum harm) to +100 (maximum benefit).

Time frame: 3 month follow up visit

ArmMeasureValue (MEAN)Dispersion
Robotic SurgeryQuality of Life Measured Using The Glasgow Children's Benefit Inventory at 3 Month Follow Up Visit14.08 score on a scaleStandard Deviation 32.42
Open SurgeryQuality of Life Measured Using The Glasgow Children's Benefit Inventory at 3 Month Follow Up Visit20.88 score on a scaleStandard Deviation 31.86
Primary

Satisfaction With Scar Appearance Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit

Participant completed the Patient Scar Assessment Questionnaire (PSAQ) at 3 month follow up visit. The 3 month follow up was scheduled at the 6 week post op visit. The Satisfaction with Appearance subscale consists of a 8 items with 4-point categorical responses, scoring 1 to 4 points (with 1 point assigned to the most favourable category and 4 assigned to the least favourable). The minimum score of this scale is an 8 and maximum 32.

Time frame: up to 3 month follow up visit (18 weeks post op)

Population: Satisfaction with Appearance at 3 month follow up

ArmMeasureValue (MEAN)Dispersion
Robotic SurgerySatisfaction With Scar Appearance Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit10.25 score on a scaleStandard Deviation 3.86
Open SurgerySatisfaction With Scar Appearance Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit11.40 score on a scaleStandard Deviation 3.05
Primary

Satisfaction With Symptoms Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit

The Patient Scar Assessment Questionnaire (PSAQ) was completed at the 3 month follow up (scheduled at the 6 week post op visit). Higher scores reflect a poorer perception of the scar related to the domain being evaluated. The Satisfaction with Symptoms subscale consists of a 5 items with 4-point categorical responses, scoring 1 to 4 points (with 1 point assigned to the most favourable category and 4 assigned to the least favourable). The minimum score of this scale is an 5 and maximum 20.

Time frame: up to 3 month follow up visit (18 weeks post op)

Population: Satisfaction with Appearance at 3 month follow up

ArmMeasureValue (MEAN)Dispersion
Robotic SurgerySatisfaction With Symptoms Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit5.50 score on a scaleStandard Deviation 1
Open SurgerySatisfaction With Symptoms Measured Using the Patient Scar Assessment Questionnaire at 3 Month Follow Up Visit7 score on a scaleStandard Deviation 2.74
Primary

Total Dose of Narcotic Pain Medication In the First 24 Hours Post Op in Morphine Milligram Equivalents (MME)

Pain medication use during hospitalization obtained via retrospective chart review. Morphine milligram equivalents (MME) are values that represent the potency of an opioid dose relative to morphine

Time frame: Surgery to the first 24 hours post op

ArmMeasureValue (MEAN)Dispersion
Robotic SurgeryTotal Dose of Narcotic Pain Medication In the First 24 Hours Post Op in Morphine Milligram Equivalents (MME)1.2 MMEStandard Deviation 1.1
Open SurgeryTotal Dose of Narcotic Pain Medication In the First 24 Hours Post Op in Morphine Milligram Equivalents (MME)0.500 MMEStandard Deviation 0.55

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026